These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17575160)

  • 1. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
    Huang J; Hu J; Bian X; Chen K; Gong W; Dunlop NM; Howard OM; Wang JM
    Cancer Res; 2007 Jun; 67(12):5906-13. PubMed ID: 17575160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation.
    El Zein N; D'Hondt S; Sariban E
    Cell Signal; 2010 Oct; 22(10):1437-47. PubMed ID: 20566383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells.
    Cattaneo F; Iaccio A; Guerra G; Montagnani S; Ammendola R
    Free Radic Biol Med; 2011 Sep; 51(6):1126-36. PubMed ID: 21708247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
    Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
    J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
    Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
    Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
    Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.
    Huang J; Chen K; Chen J; Gong W; Dunlop NM; Howard OM; Gao Y; Bian XW; Wang JM
    Br J Cancer; 2010 Mar; 102(6):1052-60. PubMed ID: 20197768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.
    Huang J; Chen K; Huang J; Gong W; Dunlop NM; Howard OM; Bian X; Gao Y; Wang JM
    Carcinogenesis; 2009 Feb; 30(2):348-55. PubMed ID: 19037090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of nordy on FPR function of malignant human glioma cell line U87].
    Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
    Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
    Chen JH; Bian XW; Yao XH; Gong W; Hu J; Chen K; Iribarren P; Zhao W; Zhou XD
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1368-74. PubMed ID: 16516855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.
    Huang J; Chen K; Gong W; Zhou Y; Le Y; Bian X; Wang JM
    Cancer Lett; 2008 Aug; 267(2):254-61. PubMed ID: 18433988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins (F2) isolated from grape seeds.
    Zhang FJ; Yang JY; Mou YH; Sun BS; Ping YF; Wang JM; Bian XW; Wu CF
    Chem Biol Interact; 2009 May; 179(2-3):419-29. PubMed ID: 19167369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.
    Staverosky JA; Muldoon LL; Guo S; Evans AJ; Neuwelt EA; Clinton GM
    Clin Cancer Res; 2005 Jan; 11(1):335-40. PubMed ID: 15671564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
    Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
    Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.
    Yao XH; Ping YF; Chen JH; Xu CP; Chen DL; Zhang R; Wang JM; Bian XW
    J Pathol; 2008 Aug; 215(4):369-76. PubMed ID: 18523971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.